116 related articles for article (PubMed ID: 7617693)
1. NS-3 (CG3703), an analog of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats.
Ogasawara T; Ukai Y; Tamura M; Kimura K
Pharmacol Biochem Behav; 1995 Apr; 50(4):499-503. PubMed ID: 7617693
[TBL] [Abstract][Full Text] [Related]
2. NS-3(CG3703), a TRH analog, ameliorates scopolamine-induced memory disruption in rats.
Ogasawara T; Nakagawa Y; Ukai Y; Tamura M; Kimura K
Pharmacol Biochem Behav; 1995 Aug; 51(4):929-34. PubMed ID: 7675879
[TBL] [Abstract][Full Text] [Related]
3. NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems.
Ogasawara T; Itoh Y; Tamura M; Ukai Y; Yoshikuni Y; Kimura K
Pharmacol Biochem Behav; 1996 Feb; 53(2):391-9. PubMed ID: 8808149
[TBL] [Abstract][Full Text] [Related]
4. NS-3, a TRH analog, reverses repeated ECS-induced deficits in water maze performance in the rat.
Khan A; Lai H; Ukai Y; Mirolo MH
Pharmacol Biochem Behav; 1994 Mar; 47(3):477-81. PubMed ID: 8208765
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents.
Yamamoto M; Shimizu M
Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):262-7. PubMed ID: 3143078
[TBL] [Abstract][Full Text] [Related]
6. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinami de, as studied by intracerebral microdialysis.
Itoh Y; Ogasawara T; Yamazaki A; Ukai Y; Miura A; Kimura K
J Pharmacol Exp Ther; 1994 Jan; 268(1):255-61. PubMed ID: 8301565
[TBL] [Abstract][Full Text] [Related]
8. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
[TBL] [Abstract][Full Text] [Related]
9. Effects of thyrotropin-releasing hormone and its analogue, NS-3, on blood pressure, heart rate, and serum catecholamine levels in rats.
Shinozuka K; Shimoura K; Hattori K
Gen Pharmacol; 1997 Feb; 28(2):209-14. PubMed ID: 9013196
[TBL] [Abstract][Full Text] [Related]
10. Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action.
Itoh Y; Ogasawara T; Mushiroi T; yamazaki A; Ukai Y; Kimura K
J Pharmacol Exp Ther; 1994 Nov; 271(2):884-90. PubMed ID: 7965809
[TBL] [Abstract][Full Text] [Related]
11. Effects of thyrotropin-releasing hormone on behavioral disturbances in middle cerebral artery-occluded rats.
Yamamoto M; Tamura A; Kirino T; Shimizu-Sasamata M; Sano K
Eur J Pharmacol; 1991 May; 197(2-3):117-23. PubMed ID: 1915564
[TBL] [Abstract][Full Text] [Related]
12. Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice.
Yamamoto M; Ozawa Y; Takeuchi H
Arch Int Pharmacodyn Ther; 1993; 321():5-13. PubMed ID: 8100705
[TBL] [Abstract][Full Text] [Related]
13. Memory deficits following internal capsule lesions in rats and their improvement by L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide (RGH-2202), a thyrotropin-releasing hormone analogue.
Oka M; Ito T; Furukawa K; Karasawa T; Kadokawa T
Arch Int Pharmacodyn Ther; 1990; 306():18-33. PubMed ID: 1981666
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer.
Ogasawara T; Itoh Y; Tamura M; Mushiroi T; Ukai Y; Kise M; Kimura K
Pharmacol Biochem Behav; 1999 Sep; 64(1):41-52. PubMed ID: 10494996
[TBL] [Abstract][Full Text] [Related]
15. Comparison of TRH and its analog (NS-3) in thermoregulatory and cardiovascular effects.
Huang XC; Saigusa T; Iriki M
Peptides; 1992; 13(2):305-11. PubMed ID: 1409009
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats.
Yamamura M; Kinoshita K; Nakagawa H; Ishida R
Jpn J Pharmacol; 1991 Feb; 55(2):241-53. PubMed ID: 1906119
[TBL] [Abstract][Full Text] [Related]
17. Effects of RGH 2202 on cognitive and motor behavior of the rat.
Drago F; Coppi G; Antonuzzo PA; Valerio C; Genazzani AA; Grassi M; Raffaele R; Scapagnini U
Neurobiol Aging; 1996; 17(1):67-71. PubMed ID: 8786805
[TBL] [Abstract][Full Text] [Related]
18. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
Asai H; Watanabe Y; Yamauchi-Kohno R; Doi O
J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new TRH analogue, YM-14673, on disturbance of passive avoidance learning in senescence-accelerated mice.
Yamamoto M; Iwai A; Ozawa Y
Pharmacol Biochem Behav; 1990 Mar; 35(3):727-9. PubMed ID: 2111030
[TBL] [Abstract][Full Text] [Related]
20. [Interaction with cholinergic drugs in reversal of cycloheximide-induced amnesia by thyrotropin-releasing hormone and its analog DN-1417 in mice].
Yamazaki N; Shintani M; Saji Y; Nagawa Y
Yakubutsu Seishin Kodo; 1983 Dec; 3(3):127-36. PubMed ID: 6431710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
